Cargando…

Changing Pattern of Opioid Users Attending an Opioid Agonist Treatment Clinic in North India

Objectives Illicit opioid use is a major concern across the globe due to its adverse health consequences. Pharmacological intervention is regarded as the cornerstone of management of opioid dependence and the Opioid Agonist Treatment (OAT) is the most effective intervention for this chronic relapsi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhat, Fazle R., Rather, Yasir H., Rasool, Ubaid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187399/ https://www.ncbi.nlm.nih.gov/pubmed/35694070 http://dx.doi.org/10.1055/s-0041-1736509

Ejemplares similares

Pattern and prevalence of substance use and dependence in two districts of Union Territory of Jammu & Kashmir: Special focus on opioids
por: Rather, Yasir Hassan, et al.
Publicado: (2021)

Chasers versus injectors : A study of heroin users from Kashmir
por: Bhat, Fazle Roub, et al.
Publicado: (2022)

Course and Correlates of Stigma in Patients on Opioid Agonist Treatment: A Prospective Study from an Outpatient Treatment Program in India
por: Ghosh, Abhishek, et al.
Publicado: (2021)

Interim opioid agonist treatment for opioid addiction: a systematic review
por: Samsó Jofra, Laura, et al.
Publicado: (2022)

Opioid Prescription Consumption Patterns After Total Joint Arthroplasty in Chronic Opioid Users Versus Opioid Naive Patients
por: Kaidi, Austin C., et al.
Publicado: (2020)

Alcohol use in opioid agonist treatment
por: Nolan, Seonaid, et al.
Publicado: (2016)

Better agonist for the opioid receptors
por: Badshah, Syed Lal, et al.
Publicado: (2018)

Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes
por: Day, Nathaniel, et al.
Publicado: (2022)

The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.
por: Bharat, Chrianna, et al.
Publicado: (2022)

Clinicoepidemiological and Patch Test Profile of Patients Attending the Contact Dermatitis Clinic of a Tertiary Care Hospital in North India: A 7-Year Retrospective Study
por: Hassan, Iffat, et al.
Publicado: (2019)

What is the benefit of inconsistent opioid agonist treatment in patients with prescription opioid use disorder?
por: Weiss, R., et al.
Publicado: (2023)

Full Opioid Agonists and Tramadol: Pharmacological and Clinical Considerations
por: Edinoff, Amber N., et al.
Publicado: (2021)

Prevalence and Pattern of Dermatological Manifestations Among Substance Users Across Kashmir Valley in North India
por: Aslam, Aaqib, et al.
Publicado: (2022)

Therapeutic Potential of Kappa Opioid Agonists
por: Beck, Tyler C., et al.
Publicado: (2019)

Co-prescription of opioids with benzodiazepine and other co-medications among opioid users: differential in opioid doses
por: Zin, Che Suraya, et al.
Publicado: (2017)

Sociodemographic profile and pattern of opioid abuse among patients presenting to a de-addiction centre in tertiary care Hospital of Kashmir
por: Farhat, Samina, et al.
Publicado: (2015)

Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors
por: Shen, Qianwei, et al.
Publicado: (2017)

Rescue Analgesia for Opioid-Dependent Individuals on Opioid Agonist Treatment during Hospitalization: Adherence to Guideline Treatment
por: Arnet, Isabelle, et al.
Publicado: (2023)

Recent changes in trends of opioid overdose deaths in North America
por: Imtiaz, Sameer, et al.
Publicado: (2020)

Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study
por: Larney, Sarah, et al.
Publicado: (2018)

Ligand-Specific Regulation of the Endogenous Mu-Opioid Receptor by Chronic Treatment with Mu-Opioid Peptide Agonists
por: Murányi, Marianna, et al.
Publicado: (2013)

Prevalence of Opioid Dependence and Opioid Agonist Treatment in the Berlin Custodial Setting: A Cross-Sectional Study
por: von Bernuth, Kira, et al.
Publicado: (2020)

Trends in Rates of Opioid Agonist Treatment and Opioid-Related Deaths for Youths in Ontario, Canada, 2013-2021
por: Rosic, Tea, et al.
Publicado: (2023)

Biphalin—A Potent Opioid Agonist—As a Panacea for Opioid System-Dependent Pathophysiological Diseases? †
por: Redkiewicz, Patrycja, et al.
Publicado: (2021)

Challenges in implementing opioid agonist therapy in Lebanon: a qualitative study from a user’s perspective
por: Ghaddar, Ali, et al.
Publicado: (2018)

Evaluation of the abuse potential of difelikefalin, a selective kappa‐opioid receptor agonist, in recreational polydrug users
por: Shram, Megan J., et al.
Publicado: (2021)

Mentalization in young patients undergoing opioid agonist treatment: Implications for clinical management
por: Pischiutta, Livia, et al.
Publicado: (2023)

Perceptions and experiences of patients attending an opioid substitution clinic in South Africa
por: Domingo, Abdul K., et al.
Publicado: (2022)

Association of Opioid Dose Reduction With Opioid Overdose and Opioid Use Disorder Among Patients Receiving High-Dose, Long-term Opioid Therapy in North Carolina
por: DiPrete, Bethany L., et al.
Publicado: (2022)

Opioid substitution therapy in manipur and nagaland, north-east india: operational research in action
por: Armstrong, Gregory, et al.
Publicado: (2010)

Trends in smoking during pregnancy stratified by the use of opioid agonist therapy and the contribution of smoking to poor outcome in neonates prenatally exposed to opioid agonist treatment
por: Kelty, Erin, et al.
Publicado: (2023)

The current status of opioid maintenance treatment in France: a survey of physicians, patients, and out-of-treatment opioid users
por: Benyamina, Amine
Publicado: (2014)

First-time admissions for opioid treatment: cross-sectional and descriptive study of new opioid users seeking treatment
por: Flórez, Gerardo, et al.
Publicado: (2015)

Forebrain delta opioid receptors regulate the response of delta agonist in models of migraine and opioid-induced hyperalgesia
por: Dripps, Isaac J., et al.
Publicado: (2020)

Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review
por: Soyka, Michael
Publicado: (2021)

Examining Brain Networks in Prescription Opioid Users
por: Ray, Suchismita
Publicado: (2017)

Tolerance to Opioid‐Induced Respiratory Depression in Chronic High‐Dose Opioid Users: A Model‐Based Comparison With Opioid‐Naïve Individuals
por: Algera, Marijke Hyke, et al.
Publicado: (2020)

Novel Mixed NOP/Opioid Receptor Peptide Agonists
por: Pacifico, Salvatore, et al.
Publicado: (2021)

A systematic review of health economic models of opioid agonist therapies in maintenance treatment of non-prescription opioid dependence
por: Chetty, Mersha, et al.
Publicado: (2017)

Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder
por: Thakrar, Ashish P., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ak06pv5pan2mtcli3gphcim396